HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay
HPV vaccination is significantly impacting both vaccine and non-vaccine type prevalence, reducing the incidence of vaccine types with concomitant increase of certain non-target types. This apparent dynamic equilibrium has important implications for cervical cancer screening and future incidence of cervical disease.
Authors
- Didier Morel
- Phil Stephenson
- Laurence M. Vaughan (ORCID: https://orcid.org/0000-0003-2976-3215)
- Alanna Woodward
- Jeffrey Andrews
- Jennifer Bull
- Valentin Parvu
Institutions
- Bellingham Technical College (US)
- Becton Dickinson (France) (FR)
- Radiology Associates (US)
- Advanced Cell Diagnostics (United States) (US)
- Covenant Health System (US)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1016/j.ygyno.2026.02.016
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00